期刊文献+

原发性高血压患者血清维生素D水平及相关性研究 被引量:6

Association between primary hypertension and serum vitamin D levels
下载PDF
导出
摘要 目的了解原发性高血压患者血清维生素D的变化,并探讨维生素D对原发性高血压发展的影响。方法按危险因素将140例原发性高血压患者分为低危组(1级高血压且无其他危险因素,56例)、中危组(2级高血压或1级高血压伴1—2个危险因素,53例)和高危组(3级高血压或1~2级高血压伴I〉3个危险因素或任何一级高血压伴1项靶器官损害或1种临床疾患,31例),并设立对照组(体检健康者,33例),检测4组的血清钙、磷、25-羟基维生素职[25(OH)D,]、甲状旁腺激素(PrH)。结果低危、中危、高危组25(OH)D,分别为(27±6)、(27±5)、(21±5)μg/L,对照组为(32±8)μg/L,低危组与中危组之间差异无统计学意义(P〉0.05),其余各组之间差异有统计学意义(P〈0.05)。25(OH)D,与收缩压、舒张压存在负相关(r值分别为-0.412、-0.377,均P〈0.01),与PTH、钙、磷、年龄无明显相关性。结论原发性高血压患者血清维生素D水平降低,尤其是伴有高危因素的患者血清维生素D水平降低更明显。 Objective To investigate the changes of serum vitamin D levels in primary hypertension pa- tients. Methods According to risk factors, 56 patients were selected as low risk group; 53 patients were selected as intermediate risk group; 31 patients were selected as high risk group and 33 healthy subjects were selected as nor- real control group. The 25-hydroxyvitamin D3 was measured with enzyme-linked immunoassay(ELISA). The statisti- cal data was analyzed by SPSS 18. 0 software. Results The sex and age of four groups objects were not significantly different. The 25 (OH)D3 of low risk group was (27 ± 6 ) μg/L; the 25 (OH) D3 of intermediate risk group was ( 27 ± 5 ) μg/L. The 25 (OH) D3 of high risk group was ( 21± 5 ) μg/L. The 25 (OH) D3 of the healthy subjects was (32 + 8)Ixg/L. The 25(OH) D3 of low risk and high risk and the healthy groups objects were significantly different (P 〈 0. 05). With simple regression analysis, the 25 (OH) D3 was positively associated with systolic pressure and diastolic pressure (r = -0. 412, -0. 377, all P 〈 0. 01 ) , but not significantly associated with the parathyroid hor- mone, calcium, phosphorous and age. Conclusion There is a high level of hypovitaminosis D in primary hyperten- sion patients.
出处 《中国医药》 2012年第11期1357-1358,共2页 China Medicine
关键词 高血压病 25-羟基维生素D3 甲状旁腺激素 Hypertension 25-hydroxyvitamin D3 Parathyroid hormone
  • 相关文献

参考文献8

  • 1Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med,2007,167( 11 ) :1159-1165.
  • 2刘力生,王文,姚崇华.中国高血压防治指南(2009年基层版)[J].中华高血压杂志,2010,18(1):11-30. 被引量:861
  • 3方永鹏,牛旭东,石学宁,谢晓敏,郝蕊.老年原发性高血压患者动态血压的相关研究[J].中国医药,2007,2(1):6-7. 被引量:11
  • 4Scragg RK, Camargo CA Jr, Simpson RU. Relation of serum 25- hydroxyvitamin D to heart rate and cardiac work (from the National Healthand Nutrition Examination Surveys ). Am J Cardiol, 2010, 105 ( 1 ) : 122-128.
  • 5Pfeifer M, Begerow B, Minne HW, et al. Effects of a short-term vitamin D (3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab ,2001, 86 (4) : 1633-1637.
  • 6Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydmxyvitamin D levels and risk of incident hypertension. Hypertension, 2007,49(5 ) : 1063-1069.
  • 7Teresa Johnson, Glenda Avery, Laura Byham-Gray. Vitamin D and Metabolic Syndrome. Top Clin Nutr, 2009,24( 1 ) : 47-54.
  • 8Wu-Wong JR. Potential for vitamin D receptor agonists in the treatment of cardiovascular disease. Br J Pharmacol,2009,158(2) :395-412.

共引文献870

同被引文献52

  • 1孙桂枝,闫静慧.240例高血压患者24h动态血压临床分析.中国医师杂志,2011,13(z1):77.
  • 2Seragg R,Sowers M,Bell C. Serum 25-hydroxyvitamin D,ethnici-ty.and blood pressure in the Third National Health and Nutrition Examination Survey[J].{H}American Journal of Hypertension,2007.713-719.
  • 3Martins D,Wolf M,Pan D. Prevalemce of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin Din the United States:data from the Third National Health and Nutrition Examination Survey[J].{H}Archives of Internal Medicine,2007.1159-1165.
  • 4Reis JP,von Mamen D,Miller ER 3rd. Vitamin D status and eardiometabolic risk factors in the united states adolescent popu-lation[J].{H}PEDIATRICS,2009.371-379.
  • 5Yuan W,Pan W,Kong J. 1,25-dihydroxyvitamin D3 sup-presses renin gene transcription by blocking the activity of the ey-clic AMP response element in the renin gene promoter[J].{H}Journal of Biological Chemistry,2007.29821-29830.
  • 6孙桂枝,闫静慧.240例高血压患者24h动态血压临床分析[J].中国医师杂志,2011(1):77.
  • 7段继豪,翟亚东,万会丽.依那普利联合硝苯地平缓释片治疗糖尿病合并高血压的疗效观察[J].社区医学杂志,2010,8(2):12-13. 被引量:14
  • 8刘力生,王文,姚崇华.中国高血压防治指南(2009年基层版)[J].中华高血压杂志,2010,18(1):11-30. 被引量:861
  • 9吉薇,蒋雄京.维生素D状态与心血管危险[J].心血管病学进展,2010,31(3):327-331. 被引量:22
  • 10江世亭,汤仁礼,余赛英,张炜,胡亮亮.硝苯地平缓释片治疗高血压合并糖尿病疗效观察[J].山东医药,2010,50(21):67-68. 被引量:70

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部